Maghanoy, Zaldy S.
HRN: 26-78-84 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/10/2025
CEFTRIAXONE 1G (VIAL)
03/10/2025
03/17/2025
IV
2g
Q24
TBI
Waiting Final Action
Indication: Prophylaxis Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes